Search clinical trials for: PD-1 Antibody
Total 53797 results
-
First Affiliated Hospital of Guangxi Medical UniversityRecruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingLymphoma | Cervical Cancer | Malignant Mesothelioma | Advanced Solid Tumours | Non-Small-Cell Lung CancerChina
-
Hutchison Medipharma LimitedRecruiting
-
Diwakar DavarMerck Sharp & Dohme LLCActive, not recruitingSquamous Cell CarcinomaUnited States
-
The Affiliated Hospital of Qingdao UniversityUnknown
-
Eye & ENT Hospital of Fudan UniversityNot yet recruitingNasopharyngeal Carcinoma
-
Shanghai Cell Therapy Research InstituteUnknownAdvanced Solid TumorChina
-
Zhejiang UniversityCompletedPancreatic CancerChina
-
Tianjin Medical University Cancer Institute and...RecruitingLocally Advanced Gastric AdenocarcinomaChina
-
Rapa Therapeutics LLCRecruitingBreast Cancer | Head and Neck Cancer | Gastric Cancer | Solid Tumor | Bladder Cancer | Triple Negative Breast Cancer | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Malignant Melanoma | Carcinoma of Unknown Primary | Squamous Cell Carcinoma of Larynx | Squamous Cell Carcinoma of Oral Cavity | Squamous Cell Carcinoma of Nasopharynx and other conditionsUnited States
-
Hunan Cancer HospitalCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Harbin Medical UniversityNot yet recruitingHepatocellular CarcinomaChina
-
Pyrotech Therapeutics, Inc.RecruitingLocally Advanced or Metastatic Solid TumorsUnited States
-
Peking University First HospitalYiZhou International Cancer HospitalUnknownImmunotherapy | Proton Therapy
-
Guangzhou Gloria Biosciences Co., Ltd.CompletedAdvanced Solid TumorsChina
-
Sun Yat-sen UniversityRecruitingEsophageal Squamous Cell Carcinoma | Oligometastatic DiseaseChina
-
Shanghai Jiao Tong University Affiliated Sixth...RecruitingCervical Cancer | Radiotherapy | Neoadjuvant Chemotherapy | PD-1 AntibodyChina
-
Merck Sharp & Dohme LLCRecruitingEsophageal Squamous Cell CarcinomaJapan, Korea, Republic of, Taiwan, China, Italy, Switzerland, Brazil, Germany, Singapore, Turkey, Thailand, Chile, Norway
-
Merck Sharp & Dohme LLCActive, not recruitingEsophageal Squamous Cell Carcinoma (ESCC)Japan, Italy, Brazil, Chile, France, Germany, Korea, Republic of, Norway, Singapore, Switzerland, Taiwan, Thailand, Turkey
-
Merck Sharp & Dohme LLCActive, not recruitingRenal Cell CarcinomaUnited States, Argentina, Australia, Brazil, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, United Kingdom
-
Wuhan Union Hospital, ChinaRecruitingNon Small Cell Lung CancerChina
-
Zhejiang Cancer HospitalNot yet recruitingGastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and SurgeryChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingChemotherapy Effect | Lung Cancer Stage IV | PD-1 Antibody | Lung Cancer Squamous CellChina
-
Merck Sharp & Dohme LLCCompleted
-
Jiangsu vcare pharmaceutical technology co., LTDCompletedHealthy Subjects | PK/PDChina
-
Chinese PLA General HospitalUnknownLymphoma | Solid TumorChina
-
Chinese PLA General HospitalLinkDoc Technology (Beijing) Co. Ltd.UnknownAdvanced Solid TumorsChina
-
Merck Sharp & Dohme LLCCompletedMerkel Cell CarcinomaUnited States, Australia, Canada, France, Italy, New Zealand, Spain, Sweden
-
Luzerner KantonsspitalNot yet recruitingPain, Postoperative | IVFSwitzerland
-
Merck Sharp & Dohme LLCActive, not recruitingSmall Cell Lung CancerPoland, Russian Federation, United States, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
-
RenJi HospitalRecruitingUrothelial Carcinoma Bladder | PD-1 InhibitorChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Zhujiang HospitalNot yet recruitingHepatocellular Carcinoma Non-resectable
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRenal Cell CarcinomaPoland, Australia, United States, Canada, France, Hungary, Ireland, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
Medical University of SilesiaMaria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,...RecruitingNewly Diagnosed GlioblastomaPoland
-
Fudan UniversityShanxi Province Cancer Hospital; Inner Mongolia Cancer Hospital Affiliated...RecruitingAdvanced Thyroid Cancer Patients Who Received Target TherapyChina
-
Sun Yat-sen UniversityChipscreen Biosciences, Ltd.Not yet recruitingRelapsed or Refractory DLBCL
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Incyte CorporationRecruitingPancreatic Cancer Metastatic | Pancreatic Cancer Non-resectableUnited States
-
Changzhou No.2 People's HospitalNot yet recruitingAdvanced Solid Tumor
-
RenJi HospitalBeiGene; Huidu Shanghai Medical Sciences LtdRecruitingUrologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Antineoplastic Agents | Tislelizumab Antineoplastic Agents, ImmunologicalChina
-
Memorial Sloan Kettering Cancer CenterXencor, Inc.Active, not recruiting
-
Merck Sharp & Dohme LLCRecruitingLymphoma, B-Cell | Lymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States, Australia, Canada, Israel, Italy, Germany
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCEisai Inc.CompletedNon-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMetastatic Non-Small Cell Lung CancerRussian Federation, Australia, United States, Argentina, Canada, Colombia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Puerto Rico, Spain, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
West China HospitalFirst Affiliated Hospital of Chongqing Medical University; Sichuan Cancer Hospital... and other collaboratorsRecruitingRectal Cancer | Radiotherapy | Anti-PD-1 Antibody | MSI-H | Mmr DeficiencyChina
-
Merck Sharp & Dohme LLCCompleted